Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more) AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Acura Pharmaceuticals Inc (EM) ACUR

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:ACUR)

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx(TM) LTX-03

GlobeNewswire March 1, 2022

Acura Pharmaceuticals Provides Development Update on LTX-03

GlobeNewswire February 14, 2022

Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results

GlobeNewswire November 15, 2021

Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results

GlobeNewswire August 16, 2021

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx(TM) LTX-03

GlobeNewswire July 26, 2021

Acura Pharmaceuticals Announces Conversion of Debt

GlobeNewswire June 14, 2021

Acura Pharmaceuticals Provides Development Update on LTX-03

GlobeNewswire June 7, 2021

Acura Pharmaceuticals Announces First Quarter Ended March 31, 2021 Financial Results

GlobeNewswire May 17, 2021

Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 31, 2021
View More News ››

Opinion & Analysis (EXPM:ACUR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:ACUR)

get out

going down fast!
Caly77 - November 23, 2010

definately holding up

this stock is doing good now......finally
Caly77 - November 15, 2010

Very nice day

so no news but a nice day just hope it picks up past the 3$ mark.
Caly77 - November 8, 2010

any news?

any1 have any idea when this stock will start going up again?
Caly77 - November 7, 2010

stock price

need some pain medication .......52 week low!!! 
beame10 - November 28, 2007

RE: NEWS!!!

found a good chat board for ACUR. http://messages.finance.yahoo.com/mb/ACUR.OB
rrspsrme - November 5, 2007
View more Bullboard ››

Almonty Industries Inc.

Almonty Industries Inc.

Almonty Industries Inc. engages in mining, processing, and shipping of tungsten concentrate. The company explores for tin and ...
View More »

Podcasts